This compound is a phosphorylated nucleotide derivative used as a prodrug intermediate in the manufacturing of adefovir, an antiviral agent. It features a purine base linked to a phosphonate ester with a pivaloyloxymethyl protecting group, contributing to its role in pharmaceutical synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Adefovir dipivoxil
pharmaceutical raw material
Adefovir monopivoxil
pharmaceutical raw material
6-(Boc-amino)hexyl bromide
pharmaceutical intermediate
N-(5-Bromo-6-methylpyridin-2-yl)acetamide
pharmaceutical intermediate
Methyl [E]-2-[3-(S)-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate
pharmaceutical intermediate
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol
pharmaceutical intermediate
[2-(6-aminopurin-9-yl)ethoxymethyl-ethoxyphosphoryl]oxymethyl 2,2-dimethylpropanoate
NOZLVTCICOSPFI-UHFFFAOYSA-N
CCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.